Needham Initiates Coverage On Praxis Precision Medicine With Buy Rating, Announces Price Target of $145
Needham Initiates Coverage On Praxis Precision Medicine With Buy Rating, Announces Price Target of $145
Needham以買入評級啓動Praxis Precision Medicine，宣佈目標價格爲145美元。
Needham analyst Ami Fadia initiates coverage on Praxis Precision Medicine (NASDAQ:PRAX) with a Buy rating and announces Price Target of $145.
Needham分析師Ami Fadia開始對Praxis Precision Medicine（納斯達克代碼：PRAX）進行買入評級，並宣佈目標價格爲145美元。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。